Medical Science

  • Home

Volume 27, Issue 135, May 2023

Role of a subanesthetic dose of ketamine for perioperative analgesia in a patient of cerebral palsy posted for spasticity corrections of lower limbs: A case report

Maitri Patel1♦, Vijay Chandak2, Kashyap Kanani3

1Junior Resident, Department of Anaesthesiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India
2Associate Professor, Department of Anaesthesiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India
3Junior Resident, Department of Orthopaedics, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India

♦Corresponding author
Junior Resident, Department of Anaesthesiology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, Wardha, Maharashtra, India

ABSTRACT

Spastic type of cerebral palsy is the commonest disorder is associated with childhood disability. For spasticity corrections, orthopedic procedures are performed which are extremely painful. So, adequate pain relief is the priority during the immediate postoperative period for good perioperative outcomes. Ketamine being an N-Methyl D aspartate (NMDA) receptor antagonist blunts central pain sensation at a subanesthetic dose (0.3mg/kg or less IV) and is used as an adjuvant for perioperative analgesia. A subanesthetic dose has a minimal physiological impact as compared to an anesthetic dose. Ketamine, as a subanesthetic dose improves pain score and decreases opioid consumption during the perioperative period. We present, a case of a twelve-year-old female child known case of cerebral palsy came for spasticity correction of lower limbs under general anesthesia.

Keywords: Spastic diplegia, N-Methyl D aspartate (NMDA), perioperative analgesia

Medical Science, 2023, 27, e236ms2689
PDF
DOI: https://doi.org/10.54905/disssi/v27i135/e236ms2689

Published: 23 May 2023

Creative Commons License

© The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution License 4.0 (CC BY 4.0).